Ordenar

Buscar

01/09/2024 Midostaurin Plus Intensive Chemotherapy in FLT3-Mutated AML: "Real-Life" Data Versus the RATIFY Study
Bobes, A, Tormo, M, Diaz-Beya, M, Beneit, P, Botella, C, Moreno, AF, Mayol, AS, Sangerman, MA, Bermejo, AY, Amigo, MD, Labrador, J, Guinon, AG, Garrido, A, Serrano, J, Polo, SV, Fortes, MG, Sayas, MJ, Bergua, JM, Olave, MT, Vall-Llovera, F, Bargay, J, Sanchez, MP, Boyero, RG, Diaz-Lopez, A, de la Fuente, A. Midostaurin Plus Intensive Chemotherapy in FLT3-Mutated AML: "Real-Life" Data Versus the RATIFY Study. Clinical Lymphoma Myeloma & Leukemia. 2024; 24DOI:. PMID:. IF:2.700(Q2/4D).
01/09/2024 Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria
Kirkegaard-Biosca, C, del Barrio-Tofiño, E, Villamarín, M, Larrosa, N, Campany, D, González-López, JJ, Ferrer, R, Viñado, B, Doménech, L, Sellarès-Nadal, J, Escolà-Vergé, L, Fernández-Hidalgo, N, Los-Arcos, I. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria. Antibiotics-Basel. 2024; 13(9)DOI:10.3390/antibiotics13090874. PMID:39335047. IF:4.600(Q1/2D).
01/09/2024 Paradoxical cell targeting of calreticulin-empowered, protein-only nanoparticles
Parladé, E, García-Leon, A, Voltà-Durán, E, Unzueta, U, Mangues, R, Casanova, I, Villaverde, A, Váquez, E. Paradoxical cell targeting of calreticulin-empowered, protein-only nanoparticles. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS. 2024; 202DOI:10.1016/j.ejpb.2024.114410. PMID:39004320. IF:4.300(Q1/2D).
01/09/2024 Overview of Thigh and Leg Anatomical and Sonographic Landmarks in Rheumatic Patients
Balius, R, Pedret, C, Estrada-Alarcón, P, Corominas, H. Overview of Thigh and Leg Anatomical and Sonographic Landmarks in Rheumatic Patients. European Journal Of Rheumatology. 2024; 11DOI:10.5152/eurjrheum.2022.21131. PMID:36052637. IF:(Q/D).
01/09/2024 A re-assessment of the value of markers of corticosteroid contact allergy in the Spanish baseline series: Clobetasol propionate in the spotlight
Mercader-García, P, Silvestre, JF, Navarro-Triviño, FJ, Giménez-Arnau, AM, Pastor-Nieto, MA, Cordoba-Guijarro, S, Melé-Ninot, G, Tous-Romero, F, González-Pérez, R, Ruiz-González, I, Sánchez-Pérez, J, Gática-Ortega, ME, Sánchez-Pedreño, P, Miquel-Miquel, J, Ortiz-Frutos, J, Carrascosa, JM, Serra-Baldrich, E, Sanz-Sanchez, T, Soria-Aledo, V, Carrillo, A, Borrego, L. A re-assessment of the value of markers of corticosteroid contact allergy in the Spanish baseline series: Clobetasol propionate in the spotlight. CONTACT DERMATITIS. 2024; 91(3)DOI:10.1111/cod.14639. PMID:38965446. IF:4.600(Q1/1D).
01/09/2024 [Translated article] Improvements in the Management of Patients With Generalized Pustular Psoriasis in Spain: Recommendations From a Group of Experts.
Rivera-Díaz R, Carrascosa Carrillo JM, Alfonso Zamora S, Navarro Valdivieso JP, Muñoz Cabello B, Ros Abarca S, Soria de Francisco JM, Daudén Tello E. [Translated article] Improvements in the Management of Patients With Generalized Pustular Psoriasis in Spain: Recommendations From a Group of Experts.. Actas Dermo-Sifiliograficas. 2024; 115(8)DOI:10.1016/j.ad.2024.07.012. PMID:38972580. IF:(Q/D).
01/09/2024 Progression of Quality of Life in Patients with Plaque Psoriasis Who Achieved Three or More Years of Complete Skin Clearance with Guselkumab Treatment: a Post hoc Analysis of the VOYAGE 1 Clinical Trial
Puig, L, Costanzo, A, de Jong, EMGJ, Torres, T, Warren, RB, Wapenaar, R, Wegner, S, Gorecki, P, Gramiccia, T, Jazra, M, Buyze, J, Conrad, C. Progression of Quality of Life in Patients with Plaque Psoriasis Who Achieved Three or More Years of Complete Skin Clearance with Guselkumab Treatment: a Post hoc Analysis of the VOYAGE 1 Clinical Trial. Dermatology and Therapy. 2024; 14(9)DOI:10.1007/s13555-024-01245-6. PMID:39153060. IF:4.200(Q1/1D).
31/08/2024 Update on Cytomegalovirus Infection Management in Allogeneic Hematopoietic Stem Cell Transplant Recipients. A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
Piñana, JL, Giménez, E, Vázquez, L, Marcos, MA, Guerreiro, M, Duarte, R, Pérez, A, de Miguel, C, Espigado, I, González-Vicent, M, Suarez-Lledó, M, García-Cadenas, I, Martino, R, Cedillo, A, Rovira, M, de la Cámara, R, Navarro, D, Solano, C. Update on Cytomegalovirus Infection Management in Allogeneic Hematopoietic Stem Cell Transplant Recipients. A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC). Mediterranean Journal of Hematology and Infectious Diseases. 2024; 16(1)DOI:10.4084/MJHID.2024.065. PMID:39258183. IF:1.500(Q3/8D).